Haemonetics (NYSE:HAE) Receives “Strong-Buy” Rating from Raymond James
Raymond James reiterated their strong-buy rating on shares of Haemonetics (NYSE:HAE – Free Report) in a research note released on Friday,Benzinga reports. The brokerage currently has a $115.00 price target on the medical instruments supplier’s stock, down from their prior price target of $120.00. HAE has been the topic of a number of other research […]
More Stories
491 Fugitives Hiding in Public Housing Arrested in Nationwide Sweep
By Naveen Athrappully A multi-month law enforcement operation has led to the arrests of 491 criminal fugitives living in government-assisted...
Trump Doubles Down on $5,000 Payments Tied to Midterm Results
By Jack Phillips President Donald Trump on Monday released a new advertisement that doubled down on his promise to send...
Zelenskyy Says Strikes on Russian Refineries Will Continue If Putin Rejects Energy Ceasefire
By Owen Evans Ukraine will continue its long-range strikes against Russia if Moscow doesn’t accept an energy truce, President Volodymyr...
Federal Agents Search Rep. Ilhan Omar’s Home: What We Know
By Jack Phillips The Washington home of Rep. Ilhan Omar (D-Minn.) was searched on Monday by federal agents as part...
Federal Agents Search Rep. Ilhan Omar’s Home: AP Report
By Zachary Stieber Federal agents on Oct. 12 searched the home of Rep. Ilhan Omar (D-Minn.) as part of a...
30-Year Fixed-Rate Mortgage Rate Hits 7.4 percent
By Naveen Athrappully The average weekly rate on a 30-year fixed-rate mortgage hit 7.4 percent, according to a Oct. 8...